Cytokeratin 20, AN43, PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder

Urologic Oncology: Seminars and Original Investigations

Volumn 21, Issue 4, 2003, Pages 266-270

  Gee, Jason R ^a   Montoya, Roselina G ^a   Khaled, Hussein M ^b   Sabichi, Anita L ^a   Grossman, H Barton ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (Egypt)

Author keywords

Bilharziasis; Bladder cancer; Cyclooxygenase 2; Cytokeratin 20; Prostaglandin dehydrogenase

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; CYCLOOXYGENASE 2; CYTOKERATIN 20; PROTEIN; PROTEIN AN43; UNCLASSIFIED DRUG; INTERMEDIATE FILAMENT PROTEIN; ISOENZYME; KRT20 PROTEIN, HUMAN; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; BLADDER CARCINOMA; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; BLADDER TUMOR; ENZYME IMMUNOASSAY; METABOLISM; PATHOLOGY; PROGNOSIS; TRANSITIONAL CELL CARCINOMA;

ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CYCLOOXYGENASE 2; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; IMMUNOENZYME TECHNIQUES; INTERMEDIATE FILAMENT PROTEINS; ISOENZYMES; KERATIN-20; MEMBRANE PROTEINS; NEOPLASM STAGING; PROGNOSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0142155612     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(02)00271-5     Document Type: Article

References (15)

1. Navon J.D., Soliman H., Khonsari F., Ahlering T. Screening cystoscopy and survival of spinal cord injured patients with squamous cell cancer of the bladder. J Urol. 157:1997;2109-2111
2. el-Mawla N.G., el-Bolkainy M.N., Khaled H.M. Bladder cancer in Africa update. Semin Oncol. 28:2001;174-178
3. Ristimaki A., Nieminen O., Saukkonen K., Hotakainen K., Nordling S., Haglund C. Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder. Am J Pathol. 158:2001;849-853
4. Komhoff M., Guan Y.F., Shappell H.W., et al. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Am J Pathol. 157:2000;29-35
5. Liebert M., Chen I.-L., Gebhardt D., et al. Loss of expression of prostaglandin dehydrogenase in human bladder cancers. Proc Am Assoc Cancer Res. 39:1998;118
6. Gee J.R., Chen I.-L., Montoya R.G., Sabichi A.L., Grossman H.B., Liebert M. Downregulation of prostaglandin dehydrogenase in invasive transitional cell carcinoma. Proc Am Assoc Cancer Res. 42:2001;264
7. Moll R., Lowe A., Laufer J., Franke W.W. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 140:1992;427-447
8. Suo Z., Holm R., Nesland J.M. Squamous cell carcinomas. An immunohistochemical study of cytokeratins and involucrin in primary and metastatic tumours. Histopathology. 23:1993;45-54
9. Liebert M., Wedemeyer G.A., Stein J.A., et al. Identification by monoclonal antibodies of an antigen shed by human bladder cancer cells. Cancer Res. 49:1989;6720-6726
10. McKenney J.K., Desai S., Cohen C., Amin M.B. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium - An analysis of cytokeratin 20, p53, and CD44 antigens. Am J Surg Pathol. 25:2001;1074-1078
11. Harnden P., Eardley I., Joyce A.D., Southgate J. Cytokeratin 20 as an objective marker of urothelial dysplasia. Br J Urol. 78:1996;870-875
12. Chu P., Wu E., Weiss L.M. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms a survey of 435 cases. Mod Pathol. 13:2000;962-972
13. Celis J.E., Wolf H., Ostergaard M. Bladder squamous cell carcinoma biomarkers derived from proteomics. Electrophoresis. 21:2000;2115-2121
14. Shirahama T., Sakakura C. Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder. Clin Cancer Res. 7:2001;558-561
15. Harnden P., Mahmood N., Southgate J. Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. Lancet. 353:1999;974-977